HK1122504A1 - Use of preparation of drugs for treatment and prevention of benign pigmented moles(naevi) using artemisinine and the derivatives thereof - Google Patents
Use of preparation of drugs for treatment and prevention of benign pigmented moles(naevi) using artemisinine and the derivatives thereofInfo
- Publication number
- HK1122504A1 HK1122504A1 HK09102894.4A HK09102894A HK1122504A1 HK 1122504 A1 HK1122504 A1 HK 1122504A1 HK 09102894 A HK09102894 A HK 09102894A HK 1122504 A1 HK1122504 A1 HK 1122504A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- artemisinine
- naevi
- drugs
- prevention
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH16862005 | 2005-10-20 | ||
CH5142006 | 2006-03-30 | ||
PCT/CH2006/000583 WO2007045116A1 (de) | 2005-10-20 | 2006-10-19 | Behandlung und prävention von gutartigen pigmentmalen (naevi) mit artemisinin und seinen derivaten |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1122504A1 true HK1122504A1 (en) | 2009-05-22 |
Family
ID=37528471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09102894.4A HK1122504A1 (en) | 2005-10-20 | 2009-03-26 | Use of preparation of drugs for treatment and prevention of benign pigmented moles(naevi) using artemisinine and the derivatives thereof |
Country Status (19)
Country | Link |
---|---|
US (2) | US8013011B2 (zh) |
EP (1) | EP1940383B1 (zh) |
JP (1) | JP5119155B2 (zh) |
KR (2) | KR20140126404A (zh) |
CN (1) | CN101282722B (zh) |
AT (1) | ATE511839T1 (zh) |
AU (1) | AU2006303809B2 (zh) |
BR (1) | BRPI0617647A2 (zh) |
CA (1) | CA2626704C (zh) |
DK (1) | DK1940383T3 (zh) |
ES (1) | ES2367845T3 (zh) |
HK (1) | HK1122504A1 (zh) |
IL (1) | IL190850A (zh) |
NZ (1) | NZ568049A (zh) |
PL (1) | PL1940383T3 (zh) |
PT (1) | PT1940383E (zh) |
RU (1) | RU2423974C2 (zh) |
WO (1) | WO2007045116A1 (zh) |
ZA (1) | ZA200804047B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101452061B1 (ko) * | 2012-01-10 | 2014-10-22 | 바이오스펙트럼 주식회사 | 아테미신산, 이의 유도체 및 이의 약학적으로 허용 가능한 염을 함유하는 피부 미백제 |
MX367732B (es) * | 2014-04-28 | 2019-09-04 | Epipharm Ag | Tratamiento o prevencion de queratosis seborreica utilizando artemisinina y derivados de la misma. |
CN105037384A (zh) * | 2015-05-13 | 2015-11-11 | 中国药科大学 | 新型羟基双氢青蒿素衍生物及其应用 |
CN105963244A (zh) * | 2016-01-15 | 2016-09-28 | 赵鸣 | 注射用青蒿琥酯制剂及其应用 |
CN106420381A (zh) * | 2016-08-08 | 2017-02-22 | 辛成业 | 青蒿素类成分或其组合物在皮肤护理中的新应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4191767A (en) * | 1977-01-07 | 1980-03-04 | Westwood Pharmaceuticals, Inc. | Method for treating fungal infection in mammals with imidazo [1,2-a]quinoxalines |
US4916204A (en) * | 1987-07-31 | 1990-04-10 | Massachusetts Institute Of Technology | Pure polyanhydride from dicarboxylic acid and coupling agent |
US5719197A (en) * | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
JPH03170422A (ja) * | 1989-11-22 | 1991-07-24 | Dermatologic Res Corp | 皮膚疾患の治療法 |
FR2708288B1 (fr) | 1993-07-26 | 1995-09-01 | Bio Merieux | Procédé d'amplification d'acides nucléiques par transcription utilisant le déplacement, réactifs et nécessaire pour la mise en Óoeuvre de ce procédé. |
EP0732959B1 (en) | 1993-12-07 | 1998-09-09 | SVEDMAN, Pal | Device for use in transdermal perfusion procedures |
WO1995034262A1 (en) | 1994-06-16 | 1995-12-21 | Department Of The Army, Us Government | Transdermal treatment of malaria |
CN1145224A (zh) * | 1996-01-03 | 1997-03-19 | 冯天炯 | 青蒿素作为抗真菌剂的应用 |
US5905089A (en) * | 1997-04-14 | 1999-05-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Use of sesquiterpene lactones for treatment of severe inflammatory disorders |
TWI234467B (en) * | 1997-06-04 | 2005-06-21 | Univ Michigan | Composition for inhibiting photoaging of skin |
US6127405A (en) * | 1998-07-10 | 2000-10-03 | Council Of Scientific And Industrial Research | Method for the use of alpha arteether as an anti-bacterial and anti-fungal agent |
CN1116036C (zh) * | 1999-03-16 | 2003-07-30 | 屠呦呦 | 治疗红斑狼疮和光敏性疾病的含双氢青蒿素的药物组合物 |
WO2001041730A1 (en) * | 1999-12-10 | 2001-06-14 | Unilever Plc | Cosmetic compositions and methods for lightening the skin |
AU2002305054B2 (en) * | 2001-03-16 | 2006-09-07 | Johnson & Johnson Consumer Inc. | Composition containing feverfew extract and use thereof |
AU2002350910A1 (en) * | 2001-12-06 | 2003-06-17 | Ufc Limited | Trioxane derivatives as antimalaria or anticancer compounds |
US6951846B2 (en) * | 2002-03-07 | 2005-10-04 | The United States Of America As Represented By The Secretary Of The Army | Artemisinins with improved stability and bioavailability for therapeutic drug development and application |
CN1649874A (zh) * | 2002-03-08 | 2005-08-03 | 拜耳商业服务有限责任公司 | 抗寄生虫药青蒿素衍生物(内过氧化物) |
NZ537113A (en) * | 2002-06-06 | 2007-01-26 | Univ Washington | Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
CN1304020C (zh) * | 2002-06-28 | 2007-03-14 | 广州市华立健药业有限公司 | 青蒿提取物在制备用于痤疮治疗保健的医疗外用制品中的应用 |
-
2006
- 2006-10-19 PT PT06804817T patent/PT1940383E/pt unknown
- 2006-10-19 KR KR1020147026575A patent/KR20140126404A/ko not_active Application Discontinuation
- 2006-10-19 BR BRPI0617647-0A patent/BRPI0617647A2/pt not_active Application Discontinuation
- 2006-10-19 WO PCT/CH2006/000583 patent/WO2007045116A1/de active Application Filing
- 2006-10-19 DK DK06804817.2T patent/DK1940383T3/da active
- 2006-10-19 NZ NZ568049A patent/NZ568049A/en unknown
- 2006-10-19 RU RU2008119463/15A patent/RU2423974C2/ru active
- 2006-10-19 CN CN2006800365697A patent/CN101282722B/zh active Active
- 2006-10-19 JP JP2008535868A patent/JP5119155B2/ja active Active
- 2006-10-19 AT AT06804817T patent/ATE511839T1/de active
- 2006-10-19 US US12/089,773 patent/US8013011B2/en active Active
- 2006-10-19 AU AU2006303809A patent/AU2006303809B2/en not_active Ceased
- 2006-10-19 KR KR1020087011897A patent/KR101496988B1/ko active IP Right Grant
- 2006-10-19 PL PL06804817T patent/PL1940383T3/pl unknown
- 2006-10-19 CA CA2626704A patent/CA2626704C/en active Active
- 2006-10-19 EP EP06804817A patent/EP1940383B1/de active Active
- 2006-10-19 ES ES06804817T patent/ES2367845T3/es active Active
-
2008
- 2008-04-14 IL IL190850A patent/IL190850A/en active IP Right Grant
- 2008-05-12 ZA ZA200804047A patent/ZA200804047B/xx unknown
-
2009
- 2009-03-26 HK HK09102894.4A patent/HK1122504A1/xx unknown
-
2011
- 2011-09-01 US US13/223,776 patent/US20120022150A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2626704A1 (en) | 2007-04-26 |
EP1940383A1 (de) | 2008-07-09 |
KR20140126404A (ko) | 2014-10-30 |
ES2367845T3 (es) | 2011-11-10 |
JP5119155B2 (ja) | 2013-01-16 |
CA2626704C (en) | 2015-12-15 |
KR101496988B1 (ko) | 2015-03-03 |
PL1940383T3 (pl) | 2011-11-30 |
BRPI0617647A2 (pt) | 2011-08-02 |
US8013011B2 (en) | 2011-09-06 |
CN101282722B (zh) | 2011-03-30 |
ATE511839T1 (de) | 2011-06-15 |
AU2006303809B2 (en) | 2012-11-15 |
CN101282722A (zh) | 2008-10-08 |
AU2006303809A1 (en) | 2007-04-26 |
ZA200804047B (en) | 2009-01-28 |
US20080255223A1 (en) | 2008-10-16 |
JP2009523703A (ja) | 2009-06-25 |
WO2007045116A1 (de) | 2007-04-26 |
IL190850A (en) | 2014-01-30 |
IL190850A0 (en) | 2008-11-03 |
US20120022150A1 (en) | 2012-01-26 |
WO2007045116A8 (de) | 2010-01-07 |
NZ568049A (en) | 2011-10-28 |
EP1940383B1 (de) | 2011-06-08 |
RU2008119463A (ru) | 2009-11-27 |
PT1940383E (pt) | 2011-09-14 |
DK1940383T3 (da) | 2011-09-26 |
RU2423974C2 (ru) | 2011-07-20 |
KR20080074890A (ko) | 2008-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0312573A (pt) | Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina | |
NO20060398L (no) | Anvendelse av en kombinasjon av en epidermal vekstfaktor reseptor kinase inhibitor og cytotoksiske midler for behandling og hemming av kreft | |
HUS1500048I1 (hu) | Ivermectin helyi kiszerelése dermatológiai állapotok kezelésére | |
NO20085217L (no) | Effektive pyrimidinderivater i behandlingen av kreft | |
WO2008020027A3 (en) | 2,5-dihydroxybenzene compounds for the treatment of skin cancer | |
WO2008028965A3 (en) | Inhibitors of protein phosphatase 1, gadd34 and protein phosphatase 1/gadd34 complex, preparation and uses thereof | |
WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
PL1919466T3 (pl) | Formulacje do leczenia nieprawidłowości lipoproteinowych obejmujące statynę i pochodną metylonikotynoamidu | |
HK1137352A1 (zh) | 至少種肉毒杆菌神經毒素在治療由至少種抗腫瘤藥引起的疼痛中的治療應用 | |
CY2018006I2 (el) | Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας | |
HK1122504A1 (en) | Use of preparation of drugs for treatment and prevention of benign pigmented moles(naevi) using artemisinine and the derivatives thereof | |
BRPI0518448A2 (pt) | composiÇÕes farmacÊuticas compreendendo um derivado de camptotecina | |
ATE541567T1 (de) | Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten | |
WO2008070010A3 (en) | Hydroxylamine derivatives for the treatment of stroke | |
WO2006102375A3 (en) | Methods for avoiding edema in the treatment or prevention of pparϝ-responsive diseases, including cancer | |
BRPI0717477A2 (pt) | Agente farmacêutico, método para a profilaxia ou tratamento de câncer, e, uso de um inibidor de her2 e um agente terapêutico hormonal ou agente anticâncer | |
TNSN07203A1 (en) | Pharmaceutical compositions for the treatment of cellulite | |
WO2006136428A3 (en) | Method and composition to treat skin ulcers | |
WO2009047505A3 (en) | Dexanabinol with inhibitors of braf or mek for the treatment of melanoma | |
NO20021437L (no) | Fremgangsmate til forebyggelse av colorektal kreft | |
WO2007146375A3 (en) | Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer | |
WO2006015283A3 (en) | Treatment of benign prostatic hyperplasia | |
GB0425633D0 (en) | Topical formulations for use in the treatment or prevention of dermatological conditions | |
GB0427637D0 (en) | Topical formulations for use in the treatment or prevention of skin cancers | |
RS52038B (en) | USE OF 7-BUTOXYIMINOMETHYLAMPTOTECIN FOR THE TREATMENT OF NON-PLASMA NEOPLASMS |